Published Guidance, NICE advice and quality standards

Skip to filtersSkip to results

Skip to results

Last updated date

Last updated date

Area of interest

Area of interest

Type 1 selected

Type

Guidance programme

Showing 776 to 800 of 1871

TitleReference numberPublishedLast updated
Dacomitinib for untreated EGFR mutation-positive non-small-cell lung cancerTA595
Patisiran for treating hereditary transthyretin amyloidosisHST10
Endovascular insertion of an intrasaccular wire-mesh blood-flow disruption device for intracranial aneurysmsIPG658
Low-energy contact X-ray brachytherapy (the Papillon technique) for locally advanced rectal cancerIPG659
Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolismNG89
Alcohol interventions in secondary and further educationNG135
PICO negative pressure wound dressings for closed surgical incisionsMTG43
Fluocinolone acetonide intravitreal implant for treating recurrent non-infectious uveitisTA590
Letermovir for preventing cytomegalovirus disease after a stem cell transplantTA591
Chronic obstructive pulmonary disease in over 16s: diagnosis and managementNG115
End of life care for infants, children and young people with life-limiting conditions: planning and managementNG61
Nusinersen for treating spinal muscular atrophyTA588
Blinatumomab for treating acute lymphoblastic leukaemia in remission with minimal residual disease activityTA589
Transurethral laser ablation for recurrent non-muscle-invasive bladder cancerIPG656
Ultrasound-guided high-intensity transcutaneous focused ultrasound for symptomatic uterine fibroidsIPG657
Motor neurone disease: assessment and managementNG42
Therapeutic monitoring of TNF-alpha inhibitors in rheumatoid arthritisDG36
Bisphosphonates for treating osteoporosisTA464
Long-acting reversible contraceptionCG30
Lenalidomide for treating myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormalityTA322
Lenalidomide for the treatment of multiple myeloma in people who have received at least 2 prior therapiesTA171
Lenalidomide plus dexamethasone for multiple myeloma after 1 treatment with bortezomibTA586
Lenalidomide plus dexamethasone for previously untreated multiple myelomaTA587
Cardiac contractility modulation device implantation for heart failureIPG655
Valve-in-valve TAVI for aortic bioprosthetic valve dysfunctionIPG653

Results per page

  1. 10
  2. 25
  3. 50
  4. All